London Deeptech Startup Anemo Labs Secures £700k to Advance AI-Powered Electronic Nose for Disease Detection
London‑based deeptech startup Anemo Labs secured £700k in a pre‑seed round led by Zinc and SFC Capital, with support from Innovate UK, to advance its AI‑driven electronic nose technology for non‑invasive disease screening via volatile organic compounds in urine.